Reportlinker.com

Reportlinker.com

March 27, 2008 07:45 ET

Learn about the World Marine Biotechnology Market

LONDON, UNITED KINGDOM--(Marketwire - March 27, 2008) - Reportlinker.com announces that a new market research report related to the Agricultural chemicals industry is available in its catalogue.

World Marine Biotechnology Market

This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications Analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the United States, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2012. The report profiles 87 companies including many key and niche players worldwide such as Aker BioMarine ASA, CP Kelco US, Inc., Cyanotech Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Integrin Advanced Biosystems, International Specialty Products Inc., Lonza Group Ltd, MariCal, Marinova, Martek Biosciences Corp., Mera Pharmaceuticals Inc., New England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Primex Ltd., Prolume Ltd., Sea Run Holdings Inc., and Tequesta Marine Biosciences. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions And Scope Of Study I-3

By Product Segment I-3

Biomaterials I-3

Bioactive Substances I-3

Others I-3

By End-Use Application I-3

Industrial Products I-3

Health Care/Biotechnology I-3

Consumer Products I-4

Public Services And Infrastructure I-4

Others I-4

II. EXECUTIVE SUMMARY

1. Industry Dynamics II-1

Market Scorecard II-1

Trends and Issues II-1

Medical and Industrial Sectors Garner Research Dollars II-1

Lack of R&D Investment in the Marine Biotech Industry II-2

Preserving Marine Ecology: A Prime Concern II-2

2. Marine Biotechnology - An Overview II-3

A Curtain Raiser II-3

Why are Microorganisms Crucial? II-3

Brief History II-4

Definition II-4

Sources of Marine Biotech Products II-5

Key Marine Sources and Products II-5

Select Marine-Derived Products II-5

Flora and Fauna II-6

Protista II-6

Bacteria II-6

Fungi II-6

Types of Marine Biotech Products II-6

Marine Biomaterials II-7

Marine Adhesives II-7

Marine Bioactive Substances II-7

Select Biological Materials and Chemicals Extracted from Marine Organisms II-8

Select Companies Involved in Supplying Reagents or Nutritional Products from Marine Organisms II-9

Enzymes II-9

Haloperoxidase Enzymes II-9

Thermostable DNA-Modifying Enzymes II-10

Other Marine Products and Processes II-10

Marine Biomass II-10

Marine Bio-Process II-10

Certain Significant Bio-Processes and their Application II-10

End-Use Analysis II-10

Definition II-10

Overview II-11

Application Areas II-12

Foods II-12

Nutraceuticals II-12

Medicine II-12

Cosmetics II-12 Research Tools II-13

Processing Technologies II-13

New Energy Sources II-13

Agriculture II-13

Industrial II-13

Food Safety II-14

Environmental Management II-14

Bioremediation II-14

Marine Biosurfactants II-14

Select Biosurfactants Produced from Marine Microorganisms II-15

Aquaculture and Marine Biotechnology II-15

Select Companies Carrying Out Genetic Enhancement or Aquaculture Breeding Programs II-16

Industrial Applications II-16

Healthcare II-16

Select Therapeutic Compounds in the Pipeline II-17

Select Marine Diterpenes and Their Biological Activity II-17

Select Players Involved in Biosensor/Diagnostic Activity II-17

Select Marine-Based Drugs II-17

Cytosar-U II-17

Prialt II-18

Yondelis II-18

Bryostatin II-18

Didemnin B II-18

Dehydrodidemnin B II-18

Pseudopterosins II-18

Bio-Prospecting II-18

Select Companies Involved in Bioprospecting and Bioscreening for Novel Marine-Based Compounds II-19

Consumer Products II-19

Select Macroalgal Materials and Their Application in Cosmetic Industry II-19

Public Services and Infrastructure II-20

Others II-20

Agriculture II-20

Mining II-20

An Insight into Select Marine-Origin Products II-20

Agar II-20

Major Seaweeds Used for Extracting Agar and Agarose II-20

Alginate II-21

Astaxanthin II-21

Select Producers of Natural and Synthetic Astaxanthin II-22

Carrageenan II-22

Chitin and Chitosan II-23

Chitin II-23

End-use Applications II-23

Chitosan II-24

Select Industrial Applications of Chitosan II-24

Collagen II-25

Salmon Calcitonin II-25

Research and Development Activity II-25

Medical II-25

Research on Natural Products II-25

Tackling Biotoxins II-26

Controlling Oil Spill Damage II-26

Preventing Biofouling II-26

Antifouling Coatings II-26

Coral Reefs Offer Abundant Opportunities II-26

3. Regional Market Overview II-28

United States II-28

Market Outlook II-28

Overview II-28

Aquaculture Biotechnology II-28

Rest of World II-28

Market Outlook II-28

Australia II-29

Canada II-29

China II-29

Europe II-30

United Kingdom II-30

Norway II-31

Overview II-31

Market Participants II-31

Industrial Applications II-31

Pharmaceuticals II-31

Latin America II-32

India II-32

Marine Environment Offers Abundant Opportunities for R&D Initiatives II-32

Market Participants II-32

Government Initiatives II-33

New Zealand II-33

4. Recent Industry Activity II-34

Aker BioMarine Merges with Natural ASA to Form Aker BioMarine II-34

Aker BioMarine Joins Hands with Pronova Biocare II-34

ABL Biotech to Establish New R&D Facility II-34

Aquapharm Strikes an Agreement with DowpharmaSM II-34

MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials for NPI-0052 II-34

CP Kelco Acquires Gold Millet II-34

Oman's Attempt To Excel in Marine Research II-35

Marical Inks an Agreement with ACD II-35

PharmaMar Conducts Clinical Testing of Zalypsis (R) Anti-tumor Agent II-35

Indore Biotech Inputs to Introduce Fungi-Based Biopesticides II-35

CP Kelco Merges with Noviant II-35

Marine Institute, Biotrove, and NUI'S Cooperative Research on Atlantic Salmon II-36

Jinghua Marine Biological Merges with Work Recovery Inc II-36

Albany Molecular Research and Alcon Research in Partnership II-36

Maryland-Israel Marine Biotechnology Research Program Gains Extension II-36

India to Set Up New National Institutions II-36

European Centre for Marine Biotechnology Inaugurated II-37

Diversa Collaborates with OSU II-37

PharmaMar Commences Phase I Clinical Trials of PM02734 II-37

USFDA Confers Orphan Drug Status to PharmaMar's Ovarian Cancer Drug, YONDELIS(R) II-37

PharmaMar Undertakes Phase II Clinical Trials of Aplidin (R) for Bladder and Prostate Cancers II-37

CorMatrix and Cook Biotech Enter into Research Agreement II-37 Elan Corp Receives European Approval for PRIALT(TM) (Ziconotide) II-38

5. Focus on Select Players II-39

Aker BioMarine ASA (Norway) II-39

CP Kelco US, Inc. (USA) II-39

Cyanotech Corp. (USA) II-39

Elan Corp (Ireland) II-39

FMC Corp. (USA) II-40

FMC Biopolymers AS (Norway) II-40

GlycoMar Ltd. (UK) II-40

Integrin Advanced Biosystems (UK) II-40

International Specialty Products Inc (USA) II-40

Lonza Group Ltd (Switzerland) II-41

MariCal (USA) II-41

Marinova (Australia) II-41

Martek Biosciences Corp. (USA) II-42

Mera Pharmaceuticals Inc (USA) II-42

New England Biolabs Inc (USA) II-42

PharmaMar S.A (Spain) II-42

PML Applications Ltd. (UK) II-42

Primex Ltd (Iceland) II-43

Prolume Ltd (USA) II-43

Sea Run Holdings Inc (USA) II-43

Tequesta Marine Biosciences (USA) II-44

6. Global Market Perspective II-45

Table 1: World Recent Past, Current & Future Analysis for Marine Biotechnology by Geographic Region- United States and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart) II-45

Table 2: World 10-Year Perspective for Marine Biotechnology by Geographic Region- Percentage Breakdown of Dollar Sales for United States and Rest of World Markets for Years 2003, 2007 & 2012 II-45

Table 3: World Recent Past, Current & Future Analysis for Marine Biotechnology by Product Segment- Marine Biomaterials, Marine Bioactive Substances, and Others Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart) II-46

Table 4: World 10-Year Perspective for Marine Biotechnology by Product Segment- Percentage Breakdown of Dollar Sales for Marine Biomaterials, Marine Bioactive Substances and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart) II-46

Table 5: World Recent Past, Current & Future Analysis for Marine Biotechnology by End-use Application-Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart) II-47

Table 6: World 10-Year Perspective for Marine Biotechnology by End-Use Application- Percentage Breakdown of Dollar Sales for Industrial Products, Health Care/ Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart) II-48

III. COMPETITIVE LANDSCAPE

To order this report:

World Marine Biotechnology Market

More market research reports here!

Contact Information